Deka Biosciences, Inc

deka biosciences, inc., is an early-stage biotechnology company focused on generating the next generation targeted cytokine therapies to treat cancer and inflammatory diseases. deka is developing the dual cytokine, (diakinetm) platform. diakines are comprised of optimized, stimulatory, or suppressive disease specific il-10 variants coupled to other stimulatory or suppressive cytokines via a t1/2 life extending tissue targeting, non-immunogenic scfv technology.